glp 1 agonist drugs The New GLP-1: Genetic Variants Related to
Description
Explore whether the wide health benefits of GLP1 drugssuch as blood sugar control, weight loss, heart and brain protection.
Although rare, associations with nonarteritic anterior ischemic optic neuropathy, pancreatitis, medullary thyroid carcinoma, and acute kidney injury (AKI) have been reported, primarily through pharmacovigilance and case-based evidence
Despite these findings, a clear link has yet to be established, and much of the evidence remains inconsistent
This includes integrating the latest clinical trial data and delving into potential signaling pathways and pharmacological mechanisms
The Revolutionary Role of GLP-1 Agonists and SGLT-2 Inhibitors in Managing Diabetes and Chronic Kidney Disease Shankar Chakkera, Elizabeth J
Triple agonist (GLP-1/GIP/Glucagon), under clinical investigation
